Award

Baloxavir Marboxil Xofluza Antiviral

  • UK Health Security Agency

UK6: Contract award notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-064065

Procurement identifier (OCID): ocds-h6vhtk-05ac7e (view related notices)

Published 10 October 2025, 10:45am



Scope

Reference

C338791

Description

The UK Health Security Agency wishes to establish a contract with a supplier for the supply of Baloxavir Marboxil Xofluza Antiviral


Contract 1. Baloxavir Marboxil Xofluza Antiviral

Supplier

Contract value

  • £1 excluding VAT
  • £1 including VAT

Above the relevant threshold

Award decision date

30 September 2025

Standstill period

  • End: 21 October 2025
  • 8 working days

Earliest date the contract will be signed

23 October 2025

Contract dates (estimated)

  • 1 November 2025 to 1 November 2026
  • 1 year, 1 day

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Contract locations

  • UK - United Kingdom

Procedure

Procedure type

Direct award


Supplier

ROCHE PRODUCTS LIMITED

  • Companies House: 00100674
  • Public Procurement Organisation Number: PXCG-4172-CHYM

6 Falcon Way

Welwyn Garden City

AL7 1TW

United Kingdom

Region: UKH23 - Hertfordshire

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. Baloxavir Marboxil Xofluza Antiviral


Contracting authority

UK Health Security Agency

  • NHS Organisation Data Service: U6N4T
  • Public Procurement Organisation Number: PBMQ-7576-DVGW

10 South Colonnade

London

E14 4PU

United Kingdom

Region: UKI42 - Tower Hamlets

Organisation type: Public authority - central government